Anti-Carbamylated Protein Antibodies, Tumour Necrosis Factor Alpha and Insulin Resistance in Egyptian Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus

Del Rincón, 2001, High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors, Arthritis Rheum, 44, 2737, 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# El-Barbary, 2011, Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide, J Rheumatol, 38, 828, 10.3899/jrheum.101143 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheumat, 38, 44, 10.1002/art.1780380107 Van Venrooij, 2011, Anti-CCP antibodies: the past, the present and the future, Nat Rev Rheumatol, 7, 391, 10.1038/nrrheum.2011.76 Fredi, 2019, P018 Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept, Ann Rheum Dis, 78, A6 Mohamed, 2020, Diagnostic value and clinical significance of anti-carbamylated protein (anti-CarP) antibodies in Egyptian patients with rheumatoid arthritis, Egypt Rheumatol, 42, 1, 10.1016/j.ejr.2019.04.004 Willemze, 2012, The ACPA recognition profile and subgrouping of ACPA-positive RA patients, Ann Rheum Dis, 71, 268, 10.1136/annrheumdis-2011-200421 Ibrahim, 2018, Anti-carbamylated protein antibodies in psoriatic arthritis patients: relation to disease activity, severity and ultrasonographic scores, Egypt Rheumatol, 40, 17, 10.1016/j.ejr.2017.08.002 Aletaha, 2010, 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 62, 2569, 10.1002/art.27584 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Gladman, 2002, Systemic lupus erythematosus disease activity index 2000, J Rheumatol, 29, 288 Trouw, 2012, Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis, Autoimmun Rev, 12, 318, 10.1016/j.autrev.2012.05.007 Paul, 2017, Pre-rheumatoid arthritis and its prevention, Eur J Rheumatol, 4, 161, 10.5152/eurjrheum.2017.16006 Liao, 2013, Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis, Rheumatology, 52, 45, 10.1093/rheumatology/kes243 Schoenfeld, 2013, The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review, 77 Jiang, 2014, Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies, Ann Rheum Dis, 73, 1761, 10.1136/annrheumdis-2013-205109 Montagna, 2007, Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis, Diabetes Vasc Dis Res, 4, 130, 10.3132/dvdr.2007.031 Hussein, 2017, Relation of tumor necrosis factor-alpha with insulin resistance in rheumatoid arthritis patients, Egypt J Hosp Med, 69, 2533, 10.12816/0041706 Gazareen, 2014, Study of insulin resistance in patients with systemic lupus erythematosus and rheumatoid arthritis, Menoufia Med J, 27, 215, 10.4103/1110-2098.141634 Kim, 2016, Patients with rheumatoid arthritis show altered lipoprotein profiles with dysfunctional high-density lipoproteins that can exacerbate inflammatory and atherogenic process, PLOS ONE, 11, e0164564, 10.1371/journal.pone.0164564 Mohamed, 2019, Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis, Indian J Rheumatol, 14, 37, 10.4103/injr.injr_110_18 El-Shorbagy, 2019, Clinical utility of anti-carbamylated protein antibody as a new marker in seronegative rheumatoid arthritis, Immunochem Immunopathol, 133 Elsawy, 2021, Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss, Rheumatology, 60, 1419, 10.1093/rheumatology/keaa549 Özdemir, 2018, 390 Kumar, 2017, Assessment of anti-CarP antibodies, disease activity and quality of life in rheumatoid arthritis patients on conventional and biological disease-modifying antirheumatic drugs, Reumatologia, 55, 4, 10.5114/reum.2017.66680 Elsayed, 2019, Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients, Clin Rheumatol, 38, 2683, 10.1007/s10067-019-04616-z Koca, 2009, Insulin resistance is related with oxidative stress in systemic lupus erythematosus, Anatol J Cardiol, 9 Pecani, 2016, Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases, Arthritis Res Therapy, 18, 1 Spinelli, 2018, 75, A45